Valuation: Penumbra, Inc.

Market Cap 12.8B 11.1B 10.4B 9.51B 17.96B 1,219B 18.19B 122B 47.74B 609B 48.04B 47B 2,027B P/E 2026 *
73.7x
P/E 2027 * 53x
Enterprise Value 12.35B 10.72B 10.03B 9.18B 17.33B 1,176B 17.56B 117B 46.07B 588B 46.37B 45.36B 1,956B EV / Sales 2026 *
7.74x
EV / Sales 2027 * 6.7x
Free-Float
97.11%
Yield 2026 *
-
Yield 2027 * -
1 day+0.05%
1 week+1.19%
Current month+1.19%
1 month+2.10%
3 months+0.11%
6 months-4.14%
Current year+4.53%
1 week 321.35
Extreme 321.35
325.74
1 month 315.69
Extreme 315.69
325.74
Current year 290
Extreme 290
362.41
1 year 221.26
Extreme 221.26
362.41
3 years 148
Extreme 148
362.41
5 years 114.86
Extreme 114.865
362.41
10 years 56.05
Extreme 56.05
362.41
Manager TitleAgeSince
Chief Executive Officer 64 2004-06-20
President 41 2025-08-31
Director of Finance/CFO 54 2019-12-01
Director TitleAgeSince
Chairman 64 2014-12-31
Chairman 64 2004-12-31
Director/Board Member 59 2015-03-31
Date Insider Type Main position Quantity % Market Cap.
2/13/26 Free

Founder

589 0.0015%
2/13/26 Free

Director

589 0.0015%
2/13/26 Free

General Counsel

5,742 0.0146%
Change 5-day change 1-year change 3-year change Capi.($)
+0.04%+1.19%+35.00%+28.63% 12.8B
-0.29%-0.17%+21.63%+22.61% 6.81B
+0.79%+1.85%+54.00%+30.22% 6.13B
+4.04%+5.21% - - 5.17B
-0.58%-5.13%-25.80%+35.02% 4.38B
+1.30%-2.32%-22.06%-19.73% 3.99B
+3.70%+9.37%+41.01%-39.71% 1.83B
-0.51%-5.18%-15.07%+200.51% 1.76B
+3.67%+8.27%+64.89%+0.31% 1.64B
+2.97%+5.62%-27.27%-48.43% 1.27B
Average +1.48%+0.13%+14.04%+23.27% 4.58B
Weighted average by Cap. +0.89%+0.23%+20.82%+24.60%

Financials

2026 *2027 *
Net sales 1.6B 1.38B 1.3B 1.19B 2.24B 152B 2.27B 15.17B 5.95B 75.93B 5.99B 5.86B 253B 1.8B 1.56B 1.46B 1.34B 2.53B 171B 2.56B 17.11B 6.71B 85.66B 6.76B 6.61B 285B
Net income 176M 153M 143M 131M 248M 16.81B 251M 1.68B 658M 8.4B 662M 648M 27.95B 242M 210M 197M 180M 340M 23.08B 344M 2.3B 904M 11.53B 910M 890M 38.39B
Net Debt -447M -388M -363M -332M -627M -42.58B -635M -4.25B -1.67B -21.27B -1.68B -1.64B -70.81B -729M -632M -592M -542M -1.02B -69.41B -1.04B -6.93B -2.72B -34.68B -2.74B -2.68B -115B
Logo Penumbra, Inc.
Penumbra, Inc. is a thrombectomy company, which is focused on developing technologies for challenging medical conditions, such as ischemic stroke, venous thromboembolism, such as pulmonary embolism, and acute limb ischemia. The Company's broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe. It focuses on developing, manufacturing and marketing novel products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. Some of the conditions it focuses on are Pulmonary Embolism, Deep Vein Thrombosis, Acute Limb Ischemia, Ischemic Stroke, Acute Coronary Syndrome, and Clot associated with Arteriovenous Graft or Fistula. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada, Australia and Singapore, as well as through distributors in select international markets.
Employees
4,700
Date Price Change Volume
26-08-07 US$324.97 +0.03% 90,363
26-08-06 US$324.86 +0.51% 262,161
26-08-05 US$323.21 -0.31% 282,960
26-08-04 US$324.22 +0.37% 363,249
26-08-03 US$323.02 +0.57% 328,452
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
324.86USD
Average target price
361.83USD
Spread / Average Target
+11.38%

Quarterly revenue - Rate of surprise